DocSym
β
Searchsearch
Search
(C77.5) Secondary and unspecified malignant neoplasm: intrapelvic lymph nodes
More details coming soon
796 389 in individuals diagnosis secondary and unspecified malignant neoplasm: intrapelvic lymph nodes confirmed
38 714 deaths with diagnosis secondary and unspecified malignant neoplasm: intrapelvic lymph nodes
5% mortality rate associated with the disease secondary and unspecified malignant neoplasm: intrapelvic lymph nodes
Diagnosis secondary and unspecified malignant neoplasm: intrapelvic lymph nodes is diagnosed Men are 16.88% more likely than Women
465 416
Men receive the diagnosis secondary and unspecified malignant neoplasm: intrapelvic lymph nodes
27 736 (6.0 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
330 973
Women receive the diagnosis secondary and unspecified malignant neoplasm: intrapelvic lymph nodes
10 978 (3.3 %)Died from this diagnosis.
Risk Group for the Disease secondary and unspecified malignant neoplasm: intrapelvic lymph nodes - Men and Women aged 60-64
In Men diagnosis is most often set at age 0-94
Less common in men the disease occurs at Age 0-1, 95+Less common in women the disease occurs at Age 5-14
In Women diagnosis is most often set at age 0-5, 15-95+
Disease Features secondary and unspecified malignant neoplasm: intrapelvic lymph nodes
Absence or low individual and public risk
Secondary and unspecified malignant neoplasm: intrapelvic lymph nodes - what does this mean
Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes is a type of cancer that occurs when cancer cells spread from the primary site to the intrapelvic lymph nodes. this is usually caused by the spread of the cancer cells through the lymphatic system. the cancer cells can then grow and form a tumor in the intrapelvic lymph nodes. this type of cancer can be difficult to treat, as it is often diagnosed in later stages.
What happens during the disease - secondary and unspecified malignant neoplasm: intrapelvic lymph nodes
Secondary and unspecified malignant neoplasm of the intrapelvic lymph nodes is caused by the spread of cancer cells from a primary tumor site to the intrapelvic lymph nodes. this can occur through direct invasion, hematogenous spread, or lymphatic spread. the cancer cells can then begin to grow and multiply in the lymph nodes, leading to the development of secondary or unspecified malignant neoplasms.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Imaging tests (X-ray, CT scan, MRI)
- Biopsy
- Blood tests
- Lymph node biopsy
- Ultrasound
Treatment and Medical Assistance
Main goal of the treatment: To reduce the size of the intrapelvic lymph nodes and reduce the symptoms associated with the disease.
- Surgery to remove the lymph nodes
- Chemotherapy to shrink the tumor
- Radiation therapy to kill cancer cells
- Immunotherapy to help the body fight cancer cells
- Targeted therapy to block the growth of cancer cells
- Hormone therapy to reduce the growth of cancer cells
- Stem cell transplant to replace damaged cells
- Clinical trials to test new treatments
14 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Secondary and unspecified malignant neoplasm: intrapelvic lymph nodes - Prevention
The best way to prevent secondary and unspecified malignant neoplasms of the intrapelvic lymph nodes is to maintain a healthy lifestyle that includes regular exercise, a balanced diet, and avoiding smoking and excessive alcohol consumption. additionally, regular cancer screenings and self-exams can help to catch any abnormal growths early.